Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

NCT04815083 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

57

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to closure of Sponsor business

Conditions

Breast Neoplasm Female
Breast Cancer

Interventions

DRUG: Aminolevulinic Acid Hydrochloride
DEVICE: Eagle V1.2 Imaging System
DRUG: Placebo

Sponsor

SBI ALApharma Canada, Inc.